Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Bone Reports
|
June 21, 2021
Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes
Konstantin Byrgazov, Thomas Lind, Annica J Rasmusson, et al.
Cancer Biology & Therapy
|
November 30, 2012
Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis
Ana Slipicevic, Geir Frode Øy, Anne Katrine Ree Rosnes, et al.
International Journal of Molecular Sciences
|
March 28, 2026
Genotype-Encoded UV Sensitivity in iPSC-Derived Human Melanocytes Reveals MX2 as a Physiological Amplifier of p53/p38-Mediated DNA Damage Signaling
Eric Ramirez-Salazar, Ana Slipicevic, Marina Juraleviciute, et al.
Human Pathology
|
October 24, 2007
Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma
Ben Davidson, Rivka Hadar, Anat Schlossberg, et al.
Human Pathology
|
April 12, 2016
MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma
Dag Andre Nymoen, Ana Slipicevic, Arild Holth, et al.
Therapeutic Advances in Medical Oncology
|
August 11, 2020
Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide
Konstantin Byrgazov, Claes Anderson, Benjamin Salzer, et al.
Cancer Medicine
|
July 28, 2020
Melflufen, a peptide-conjugated alkylator, is an efficient anti-neo-plastic drug in breast cancer cell lines
Alexander Schepsky, Gunnhildur Asta Traustadottir, Jon Petur Joelsson, et al.
Cells
|
May 14, 2022
Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen
Arjen Gebraad, Roope Ohlsbom, Juho J Miettinen, et al.
Molecular Oncology
|
March 27, 2024
The one-carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiation
Petra Marttila, Nadilly Bonagas, Christina Chalkiadaki, et al.
Pigment Cell & Melanoma Research
|
October 30, 2019
MX 2 is a novel regulator of cell cycle in melanoma cells
Marina Juraleviciute, Joanna Pozniak, Jérémie Nsengimana, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Bone Reports
|
June 21, 2021
Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes
Konstantin Byrgazov, Thomas Lind, Annica J Rasmusson, et al.
Cancer Biology & Therapy
|
November 30, 2012
Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis
Ana Slipicevic, Geir Frode Øy, Anne Katrine Ree Rosnes, et al.
International Journal of Molecular Sciences
|
March 28, 2026
Genotype-Encoded UV Sensitivity in iPSC-Derived Human Melanocytes Reveals MX2 as a Physiological Amplifier of p53/p38-Mediated DNA Damage Signaling
Eric Ramirez-Salazar, Ana Slipicevic, Marina Juraleviciute, et al.
Human Pathology
|
October 24, 2007
Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma
Ben Davidson, Rivka Hadar, Anat Schlossberg, et al.
Human Pathology
|
April 12, 2016
MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma
Dag Andre Nymoen, Ana Slipicevic, Arild Holth, et al.
Therapeutic Advances in Medical Oncology
|
August 11, 2020
Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide
Konstantin Byrgazov, Claes Anderson, Benjamin Salzer, et al.
Cancer Medicine
|
July 28, 2020
Melflufen, a peptide-conjugated alkylator, is an efficient anti-neo-plastic drug in breast cancer cell lines
Alexander Schepsky, Gunnhildur Asta Traustadottir, Jon Petur Joelsson, et al.
Cells
|
May 14, 2022
Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen
Arjen Gebraad, Roope Ohlsbom, Juho J Miettinen, et al.
Molecular Oncology
|
March 27, 2024
The one-carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiation
Petra Marttila, Nadilly Bonagas, Christina Chalkiadaki, et al.
Pigment Cell & Melanoma Research
|
October 30, 2019
MX 2 is a novel regulator of cell cycle in melanoma cells
Marina Juraleviciute, Joanna Pozniak, Jérémie Nsengimana, et al.
Page
of 4